Instrument Inactif

Communiqués Cambrex Corporation

Actions

CBM

Produits pharmaceutiques

Communiqués

07/04/20	Cambrex Completes Biopharmaceutical Expansion at its Durham, NC Facility	GL
31/03/20	Cambrex Appoints Troy Player as President, Early Stage Development & Testing Business Unit	GL
04/12/19	Cambrex : Announces Completion of Acquisition by the Permira Funds	AQ
14/11/19	Cambrex Wins Third API Development Award at CPhI Worldwide	GL
23/09/19	Cambrex Corporation Announces Expiration of “Go Shop” Period Under Merger Agreement	GL
13/08/19	CAMBREX INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cambrex Corporation - CBM	BU
08/08/19	Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Cambrex Corporation (NYSE: CBM) on Behalf of Cambrex Shareholders and Encourages Cambrex Investors to Contact the Firm	PR
07/08/19	Cambrex Cancels Second Quarter Earnings Conference Call and Will Not Update Financial Guidance	GL
07/08/19	Cambrex (CBM) Alert: Johnson Fistel Investigates Proposed Sale of Cambrex Corporation; Is $60 a Fair Price?	PR
07/08/19	Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash	GL
06/08/19	Cambrex to Announce Second Quarter 2019 Financial Results on August 9, 2019	GL
26/06/19	Cambrex Strengthens Leadership Team to Support Integrated Small Molecule End-to-End Service Offering	GL
25/06/19	Cambrex Appoints Dottie Donnelly-Brienza as Senior Vice President and Chief Human Resources Officer	GL
04/06/19	Cambrex Completes New Process and Analytical Development Facility at its Karlskoga, Sweden Manufacturing Site	GL
29/05/19	Cambrex to Present at Upcoming Investor Conferences in June	GL
02/05/19	Cambrex Reports First Quarter 2019 Financial Results	GL
30/04/19	Cambrex to Announce First Quarter 2019 Financial Results on May 2, 2019	GL
10/04/19	Cambrex Completes Highly Potent API Manufacturing Facility at Charles City, IA	GL
26/03/19	Cambrex Doubles cGMP Liquid Filling Capacity at its Mirabel, Québec Facility	GL
13/02/19	Cambrex Reports Fourth Quarter and Full Year 2018 Financial Results	GL
08/02/19	Cambrex to Announce Fourth Quarter and Full Year 2018 Financial Results on February 13, 2019	GL
02/01/19	Cambrex Completes Acquisition of Avista Pharma Solutions	GL
11/12/18	Cambrex Expands Analytical Capabilities at its High Point, NC Site	GL
20/11/18	Cambrex to Acquire Avista Pharma Solutions, Adding Early Stage API and Finished Dosage Form Development & Testing Services to its Global Contract Development & Manufacturing Network	GL
08/11/18	Cambrex Reports Third Quarter 2018 Financial Results	GL